← FDA Drug Approvals (Drugs@FDA)

NOVRAD

NDA · New Drug Application · Sponsor: LILLY · Approved 1962-03-21

Drug application

FDA Application #

NDA012928

Application type

New Drug Application

Brand name

NOVRAD

Generic name

Levopropoxyphene Napsylate Anhydrous

Active ingredients

LEVOPROPOXYPHENE NAPSYLATE ANHYDROUS

Dosage form

CAPSULE

Route

ORAL

Marketing status

Discontinued

Sponsor

LILLY

First approval

1962-03-21

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown